Financial News

Geron And GE Enter Joint Development

Geron Corp. (Nasdaq: GERN) and GE Healthcare, a unit of General Electric (NYSE: GE) agreed to conduct joint research to develop embryonic stem cell products. Shares of Geron climbed $1.02 to $7.71 wile GE stock slipped 15 cents to $11.61.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback